Clinical Trials Browser

brivaracetam × CNS × 30 days × Clear all

NCT05029960 2026-06-03

Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas

Phase EARLY_PHASE1 Terminated

Brain Neoplasms, Epilepsy